A recent study indicates that people who discontinue popular weight-loss injections like semaglutide or tirzepatide tend to recover reduced body mass at a significantly accelerated pace than those who end traditional diet and exercise regimens.
Findings released in a prominent health publication shows that while overweight individuals can lose substantial amounts of their body weight while undergoing treatment, the weight comes back at an estimated rate of nearly a kilo each month once they quit.
"Users buying such medications must be aware of the danger of rapid weight regain when the therapy concludes," warns expert Dr. Susan Jebb.
That rate of recovery means a return to starting mass in about 18 months.
Weighing Treatments
The analysis, which examined 37 of studies involving thousands of participants, contrasted the effects of GLP-1 agonists with other pills.
Researchers note that people who shed pounds through dieting generally have a less rapid weight regain—approximately 100 grams monthly—post-intervention.
The Reason for the Quick Regain
Doctors believe the mechanism of the jabs explains the accelerated regain.
GLP-1 drugs copy a natural hormone called GLP-1, which helps regulate feelings of fullness.
"Long-term administration of GLP-1 levels several times higher than the body's typical production could lead to the system to produce less of its own natural hormone, and may also reduce sensitivity to its effects," explained Dr. Adam Collins, a dietetics expert.
"Discontinuation of this GLP-1 'fix' means hunger is uncontrolled, making binge eating a significant risk."
A Chronic Disease?
Medical guidelines suggest the injections for people with weight-linked medical conditions, alongside recommended diet and exercise modifications.
Many experts contend that, given the significant potential of relapse, the therapy should be considered ongoing.
This view is echoed by pharmaceutical companies, who say that the results "emphasize the chronic nature of obesity," similar to managing conditions like diabetes.
Patient Accounts
People who have discontinued the jabs explain a powerful resurgence of cravings.
"I experienced something that goes on and I was suddenly extremely hungry," said an individual.
The struggle is worsened if patients have not adopted lasting dietary or behavioural changes during treatment.
Widespread Use
Figures indicate that a significant number of people in the UK have used these injections in the last 12 months, with demand being substantial.
- Use is higher among females compared to males.
- The 40s and 50s age group shows the greatest usage rates.
- A large proportion access the medications through private prescriptions rather than public health services.
Finally, researchers emphasize that while GLP-1 drugs are effective agents for shedding pounds, they are not a permanent cure and long-term success likely depends on ongoing lifestyle changes.
